Clinical Trial Update: AZD0486 1L Therapy for Elderly or Unfit Participants With LBCL [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating AZD0486 as first-line therapy for elderly or unfit patients with diffuse large B-cell lymphoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• AZD0486 (AZD0486)

Snippet

Sponsor: AstraZeneca | Conditions: Large B-cell Lymphoma | Phase 3 | Status: RECRUITING